Hypertrophic Osteoarthropathy Secondary to Lung Cancer: Beneficial Effect of Anti-vascular Endothelial Growth Factor Antibody

J Clin Rheumatol. 2017 Jan;23(1):47-50. doi: 10.1097/RHU.0000000000000441.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma of Lung
  • Adenocarcinoma* / complications
  • Adenocarcinoma* / metabolism
  • Adenocarcinoma* / pathology
  • Angiogenesis Inhibitors / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Bevacizumab / administration & dosage*
  • Bone and Bones / diagnostic imaging*
  • Cyclooxygenase 2 / metabolism
  • Humans
  • Lung Neoplasms* / complications
  • Lung Neoplasms* / metabolism
  • Lung Neoplasms* / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Osteoarthropathy, Secondary Hypertrophic* / diagnosis
  • Osteoarthropathy, Secondary Hypertrophic* / etiology
  • Radiography / methods*
  • Radionuclide Imaging / methods*
  • Radiotherapy, Intensity-Modulated / methods*
  • Superior Vena Cava Syndrome / diagnosis
  • Superior Vena Cava Syndrome / etiology
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Cyclooxygenase 2
  • PTGS2 protein, human